New cell therapy trial aims to tame dangerous transplant complication
Disease control
Recruiting now
This study is testing whether adding an investigational cell therapy called CYP-001 to standard steroid treatment works better than steroids alone for patients with high-risk acute graft-versus-host disease (GvHD). GvHD is a serious and potentially life-threatening complication t…
Phase: PHASE2 • Sponsor: Cynata Therapeutics Limited • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC